IQVIA
IQV
#856
Rank
โ‚น2.756 T
Marketcap
โ‚น16,515
Share price
-0.97%
Change (1 day)
33.10%
Change (1 year)

Revenue for IQVIA (IQV)

Revenue in 2026 (TTM): โ‚น1.488 Trillion

According to IQVIA's latest financial reports the company's current revenue (TTM ) is โ‚น1.601 Trillion. In 2025 the company made a revenue of โ‚น1.464 Trillion an increase over the revenue in the year 2024 that were of โ‚น1.321 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for IQVIA from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น1.488 T1.65%
2025 โ‚น1.464 T10.79%
2024 โ‚น1.321 T5.94%
2023 โ‚น1.247 T4.61%
2022 โ‚น1.192 T15.47%
2021 โ‚น1.032 T24.31%
2020 โ‚น830.72 B5.06%
2019 โ‚น790.69 B8.61%
2018 โ‚น728.03 B16.85%
2017 โ‚น623.05 B33.3%
2016 โ‚น467.39 B22.58%
2015 โ‚น381.29 B10.19%
2014 โ‚น346.04 B9.84%
2013 โ‚น315.04 B18.26%
2012 โ‚น266.40 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚น13.39 B-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA